CLINICAL_TRIALS
trial_result
· 2014-06-26
Clinical Trial Update: A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa [Phase 1]
Summary
A Phase 1 study evaluating the safety of CNTO 2476 in patients with advanced Retinitis Pigmentosa was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Retinitis Pigmentosa | Phase 1 | Status: TERMINATED